Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
153.53B
Market cap153.53B
Price-Earnings ratio
19.91
Price-Earnings ratio19.91
Dividend yield
6.37%
Dividend yield6.37%
Average volume
32.17M
Average volume32.17M
High today
$27.30
High today$27.30
Low today
$26.58
Low today$26.58
Open price
$26.69
Open price$26.69
Volume
42.50M
Volume42.50M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$21.97
52 Week low$21.97

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $27.00. The company's market cap stands at 153.53B, with a P/E ratio of 19.91 and a dividend yield of 6.4%.

During the trading session on 2026-04-25, Pfizer(PFE) shares reached a daily high of $27.30 and a low of $26.58. At a current price of $27.00, the stock is +1.6% higher than the low and still -1.1% under the high.

Trading volume for Pfizer(PFE) stock has reached 42.5M, versus its average volume of 32.17M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $21.97.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $21.97.

PFE News

TipRanks 1d
Bristol Myers-Pfizer Alliance launch collaboration with Mark Cuban for Eliquis

The Bristol Myers Squibb-Pfizer (BMY) – Pfizer (PFE) Alliance announced the launch of a collaboration with Mark Cuban Cost Plus Drug Company to offer Eliquis, o...

Simply Wall St 2d
Pfizer Obesity Pipeline Expands As Monthly GLP 1 Candidate Targets Growth

Pfizer (NYSE:PFE) reported positive Phase 2b results for its GLP-1 anti-obesity candidate PF-08653944, targeting once-monthly dosing. The company outlined plan...

Pfizer Obesity Pipeline Expands As Monthly GLP 1 Candidate Targets Growth
TipRanks 2d
Pfizer Advances PF-08653944 Liver Study, Reinforcing Long-Term Pipeline Visibility

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

Analyst ratings

50%

of 30 ratings
Buy
40%
Hold
50%
Sell
10%

More PFE News

TipRanks 2d
Pfizer’s New Phase 1 Cancer Trial Adds Quiet Optionality to PFE’s Pipeline

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 2d
Pfizer Advances Early-Stage Obesity Asset With New Gastric Emptying Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 2d
Pfizer Advances Early-Stage Heart Failure Candidate With Completion of Chinese Phase 1 Study

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 2d
Mixed options sentiment in Pfizer with shares down 1.29%

Mixed options sentiment in Pfizer (PFE), with shares down 34c near $26.45. Options volume roughly in line with average with 50k contracts traded and calls leadi...

24/7 Wall St. 2d
Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks

Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks By Joel South Published Apr 23, 10:07AM EDT Quick Read AT...

Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks
Nasdaq 3d
Should You Forget Pfizer and Buy This Pharma Stock Instead?

Key Points AbbVie has managed its patent-cliff concerns better. Pfizer has a higher-yielding dividend, but it may not be safe. AbbVie has the better path to...

Should You Forget Pfizer and Buy This Pharma Stock Instead?
TipRanks 3d
Notable open interest changes for April 22nd

Tuesday’s total option volume of 67.7 million contracts resulted in net open interest growth of 6.90 million calls and 7.56 million puts. NVIDIA (NVDA), Apple (...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.